Continental Advisors LLC Astrazeneca PLC Transaction History

Continental Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $229,793 - $264,563	-4,330 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $1.42 Million - $1.82 Million	-32,902 Reduced 88.37%	4,330 $229,000
Q4 2019 Feb 10, 2020	SELL	$42.46 - $50.46 $195,400 - $232,216	-4,602 Reduced 11.0%	37,232 $1.86 Million
Q1 2019 May 14, 2019	SELL	$35.49 - $43.02 $1.29 Million - $1.57 Million	-36,466 Reduced 46.57%	41,834 $1.69 Million
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $695,200 - $794,400	-20,000 Reduced 20.35%	78,300 $3.1 Million
Q4 2017 Feb 13, 2018	SELL	$32.09 - $34.78 $160,450 - $173,900	-5,000 Reduced 4.84%	98,300 $3.41 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $2.99 Million - $3.51 Million	103,300	103,300 $3.5 Million

1,333

490M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $241B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Continental Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Continental Advisors LLC with notifications on news.